254 related articles for article (PubMed ID: 28905289)
1. Lymph node-positive prostate cancer after robotic prostatectomy and extended pelvic lymphadenectomy.
Chenam A; Parihar JS; Ruel N; Pal S; Avila Y; Yamzon J; Lau C; Yuh B
J Robot Surg; 2018 Sep; 12(3):425-431. PubMed ID: 28905289
[TBL] [Abstract][Full Text] [Related]
2. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer.
Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B
Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823
[TBL] [Abstract][Full Text] [Related]
3. Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer.
Morizane S; Honda M; Shimizu R; Teraoka S; Nishikawa R; Tsounapi P; Kimura Y; Iwamoto H; Hikita K; Takenaka A
Int J Clin Oncol; 2020 Jul; 25(7):1398-1404. PubMed ID: 32333202
[TBL] [Abstract][Full Text] [Related]
4. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
5. Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
Wenger H; Weiner AB; Razmaria A; Paner GP; Eggener SE
Urol Oncol; 2017 Jan; 35(1):31.e1-31.e6. PubMed ID: 27692833
[TBL] [Abstract][Full Text] [Related]
6. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
[TBL] [Abstract][Full Text] [Related]
7. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
[TBL] [Abstract][Full Text] [Related]
8. Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management.
Linxweiler J; Sprenk J; Cascetta K; Pryalukhin A; Hölters S; Zeuschner P; Nini A; Al-Kailani Z; Ezziddin S; Bohle RM; Fries P; Ohlmann CH; Heinzelbecker J; Siemer S; Stöckle M; Junker K; Saar M
J Urol; 2021 Jul; 206(1):88-96. PubMed ID: 33617326
[TBL] [Abstract][Full Text] [Related]
9. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
10. Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes.
Linxweiler J; Saar M; Al-Kailani Z; Janssen M; Ezziddin S; Stöckle M; Siemer S; Ohlmann CH
Surg Oncol; 2018 Jun; 27(2):138-145. PubMed ID: 29937163
[TBL] [Abstract][Full Text] [Related]
11. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
[TBL] [Abstract][Full Text] [Related]
12. Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database.
Schiavina R; Bianchi L; Borghesi M; Briganti A; Brunocilla E; Carini M; Terrone C; Mottrie A; Dente D; Gacci M; Gontero P; Gurioli A; Imbimbo C; La Manna G; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Munegato S; Novara G; Panarello D; Porreca A; Russo GI; Serni S; Simonato A; Urzì D; Verze P; Volpe A; Martorana G
Int J Urol; 2016 Dec; 23(12):1000-1008. PubMed ID: 27620370
[TBL] [Abstract][Full Text] [Related]
13. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
[TBL] [Abstract][Full Text] [Related]
14. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML
J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of immediate androgen deprivation adjuvant therapy in patients with lymph node positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy].
Miyamae K; Kitani K; Miyamoto K; Hamada S; Kawano T; Maehara A; Otsuka Y; Otsuka T; Hamada Y
Nihon Hinyokika Gakkai Zasshi; 2009 Jul; 100(5):570-5. PubMed ID: 19663244
[TBL] [Abstract][Full Text] [Related]
16. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era.
Goto Y; Utsumi T; Maruo M; Kurozumi A; Noro T; Tanaka S; Sugawara S; Chiba K; Miyazaki K; Inoue A; Komaru A; Fukasawa S; Imamura Y; Sakamoto S; Nakatsu H; Suzuki H; Ichikawa T; Nagata M
Int J Urol; 2023 Aug; 30(8):659-665. PubMed ID: 37130793
[TBL] [Abstract][Full Text] [Related]
18. Initial multicentre experience of
Siriwardana A; Thompson J; van Leeuwen PJ; Doig S; Kalsbeek A; Emmett L; Delprado W; Wong D; Samaratunga H; Haynes AM; Coughlin G; Stricker P
BJU Int; 2017 Nov; 120(5):673-681. PubMed ID: 28548372
[TBL] [Abstract][Full Text] [Related]
19. [Outcome after radical prostatectomy with extended pelvic lymphadenectomy for untreated high-risk clinically localized prostate cancer].
Tsurusaki T; Yamasaki Y; Maruta S
Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):496-504. PubMed ID: 23819361
[TBL] [Abstract][Full Text] [Related]
20. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
